Results 241 to 250 of about 1,795,506 (333)
Artificial intelligence and the future of patient-centered outcomes. [PDF]
Weinfurt KP, Reeve BB.
europepmc +1 more source
Current Challenges in Hemostasis and Advances in Particle‐Assisted Styptic Devices
Here persistent limitations in hemostatic technologies are highlighted and cutting‐edge biomimetic, microparticle‐assisted, and nanoengineered systems with integrated drug delivery are showcased. Moreover, the article identifies fresh directions toward the next‐generation of multifunctional hemostatic devices with superior efficacy and accessibility ...
Daniele Baiocco +4 more
wiley +1 more source
Special Issue on Computer Chess Artificial Intelligence, Vol. 43, No.1, April 1990
H.J. Berliner, D.F. Beal
openalex +2 more sources
Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectives. [PDF]
Costa F +15 more
europepmc +1 more source
3D Printing Strategies for Bioengineering Human Cornea
This review highlights recent progress in 3D bioprinting strategies for engineering human corneas. Key aspects include the replication of corneal transparency, curvature, and biomechanical properties, alongside innovations in recent advancements in 3D printing methods, which benefit in overcoming current challenges.
Yunong Yuan +4 more
wiley +1 more source
Electrochemical Biosensor for Rapid Detection of Acute Rejection in Kidney Transplants
A low‐cost, rapid electrochemical immunosensor coated with a novel antifouling nanocomposite enables single‐step, dual‐biomarker profiling directly from unprocessed urine. Application in a clinical study shows accurate discrimination of acute rejection in kidney transplants from other acute kidney injuries via machine learning.
Rohit Gupta +9 more
wiley +1 more source
Artificial intelligence in colonoscopy: polyp fiction or clinical reality? [PDF]
Gong EJ, Bang CS.
europepmc +1 more source
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao +2 more
wiley +1 more source

